PDCD1 and neoplasm: Studies show that co-inhibitory molecules such as PD-1 and PD-L1 induce immune suppression in the tumor microenvironment (Iwai et al., 2002; Blank et al., 2006; Blackburn et al., 2009; Kataoka et al., 2016).